Hepatocyte transplantation

An alternative system for evaluating cell survival and immunoisolation

Sanjeev Gupta, S. K. Kim, R. P. Vemuru, E. Aragona, P. R. Yernemi, Robert D. Burk, C. K. Rha

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

To evaluate systems for barrier immunoisolation of transplanted hepatocytes, we used transgenic mouse hepatocytes that secrete HBsAg. Hepatocytes were rapidly encapsulated in chitosan, a cationic polymer derived by deacetylation of chitin. Chitosan was allowed to electrostatically bond with anionic sodium alginate for creating an outer bipolymer membrane of the capsules. After encapsulation, hepatocyte viability remained unchanged for seven days in vitro with secretion of HBsAg into the culture medium throughout this period. Following intraperitoneal transplantation of encapsulated hepatocytes, HBsAg promptly appeared in blood of recipients. In congeneic recipients, serum HBsAg peaked at two weeks. Hepatocytes were present in recovered chitosan capsules and expressed HBsAg mRNA. In allogeneic recipients, however, serum HBsAg disappeared within one week and recovered chitosan capsules showed lymphomononuclear cells but not hepatocytes. Transplantation of chitosan encapsulatd HbsAg secreting hepatocytes failed to induce an anti-HBs response, suggesting modulation of the host immune response. These results indicate that transplantation systems using genetically modified hepatocytes which secrete gene products in the blood of recipients should facilitate evaluation of hepatocyte encapsulation.

Original languageEnglish (US)
Pages (from-to)155-163
Number of pages9
JournalInternational Journal of Artificial Organs
Volume16
Issue number3
StatePublished - 1993

Fingerprint

Hepatocytes
Cell Survival
Transplantation
Cells
Hepatitis B Surface Antigens
Chitosan
Capsules
Encapsulation
Blood
Sodium alginate
Chitin
Serum
Transgenic Mice
Culture Media
Polymers
Genes
Modulation
Membranes
Messenger RNA

Keywords

  • bioartificial liver
  • hepatitis B virus
  • hepatocyte transplantation
  • immobilized cells
  • transgenic mouse

ASJC Scopus subject areas

  • Biophysics

Cite this

Hepatocyte transplantation : An alternative system for evaluating cell survival and immunoisolation. / Gupta, Sanjeev; Kim, S. K.; Vemuru, R. P.; Aragona, E.; Yernemi, P. R.; Burk, Robert D.; Rha, C. K.

In: International Journal of Artificial Organs, Vol. 16, No. 3, 1993, p. 155-163.

Research output: Contribution to journalArticle

Gupta, Sanjeev ; Kim, S. K. ; Vemuru, R. P. ; Aragona, E. ; Yernemi, P. R. ; Burk, Robert D. ; Rha, C. K. / Hepatocyte transplantation : An alternative system for evaluating cell survival and immunoisolation. In: International Journal of Artificial Organs. 1993 ; Vol. 16, No. 3. pp. 155-163.
@article{691d2362c4f3434798673db94ef65930,
title = "Hepatocyte transplantation: An alternative system for evaluating cell survival and immunoisolation",
abstract = "To evaluate systems for barrier immunoisolation of transplanted hepatocytes, we used transgenic mouse hepatocytes that secrete HBsAg. Hepatocytes were rapidly encapsulated in chitosan, a cationic polymer derived by deacetylation of chitin. Chitosan was allowed to electrostatically bond with anionic sodium alginate for creating an outer bipolymer membrane of the capsules. After encapsulation, hepatocyte viability remained unchanged for seven days in vitro with secretion of HBsAg into the culture medium throughout this period. Following intraperitoneal transplantation of encapsulated hepatocytes, HBsAg promptly appeared in blood of recipients. In congeneic recipients, serum HBsAg peaked at two weeks. Hepatocytes were present in recovered chitosan capsules and expressed HBsAg mRNA. In allogeneic recipients, however, serum HBsAg disappeared within one week and recovered chitosan capsules showed lymphomononuclear cells but not hepatocytes. Transplantation of chitosan encapsulatd HbsAg secreting hepatocytes failed to induce an anti-HBs response, suggesting modulation of the host immune response. These results indicate that transplantation systems using genetically modified hepatocytes which secrete gene products in the blood of recipients should facilitate evaluation of hepatocyte encapsulation.",
keywords = "bioartificial liver, hepatitis B virus, hepatocyte transplantation, immobilized cells, transgenic mouse",
author = "Sanjeev Gupta and Kim, {S. K.} and Vemuru, {R. P.} and E. Aragona and Yernemi, {P. R.} and Burk, {Robert D.} and Rha, {C. K.}",
year = "1993",
language = "English (US)",
volume = "16",
pages = "155--163",
journal = "International Journal of Artificial Organs",
issn = "0391-3988",
publisher = "Wichtig Publishing",
number = "3",

}

TY - JOUR

T1 - Hepatocyte transplantation

T2 - An alternative system for evaluating cell survival and immunoisolation

AU - Gupta, Sanjeev

AU - Kim, S. K.

AU - Vemuru, R. P.

AU - Aragona, E.

AU - Yernemi, P. R.

AU - Burk, Robert D.

AU - Rha, C. K.

PY - 1993

Y1 - 1993

N2 - To evaluate systems for barrier immunoisolation of transplanted hepatocytes, we used transgenic mouse hepatocytes that secrete HBsAg. Hepatocytes were rapidly encapsulated in chitosan, a cationic polymer derived by deacetylation of chitin. Chitosan was allowed to electrostatically bond with anionic sodium alginate for creating an outer bipolymer membrane of the capsules. After encapsulation, hepatocyte viability remained unchanged for seven days in vitro with secretion of HBsAg into the culture medium throughout this period. Following intraperitoneal transplantation of encapsulated hepatocytes, HBsAg promptly appeared in blood of recipients. In congeneic recipients, serum HBsAg peaked at two weeks. Hepatocytes were present in recovered chitosan capsules and expressed HBsAg mRNA. In allogeneic recipients, however, serum HBsAg disappeared within one week and recovered chitosan capsules showed lymphomononuclear cells but not hepatocytes. Transplantation of chitosan encapsulatd HbsAg secreting hepatocytes failed to induce an anti-HBs response, suggesting modulation of the host immune response. These results indicate that transplantation systems using genetically modified hepatocytes which secrete gene products in the blood of recipients should facilitate evaluation of hepatocyte encapsulation.

AB - To evaluate systems for barrier immunoisolation of transplanted hepatocytes, we used transgenic mouse hepatocytes that secrete HBsAg. Hepatocytes were rapidly encapsulated in chitosan, a cationic polymer derived by deacetylation of chitin. Chitosan was allowed to electrostatically bond with anionic sodium alginate for creating an outer bipolymer membrane of the capsules. After encapsulation, hepatocyte viability remained unchanged for seven days in vitro with secretion of HBsAg into the culture medium throughout this period. Following intraperitoneal transplantation of encapsulated hepatocytes, HBsAg promptly appeared in blood of recipients. In congeneic recipients, serum HBsAg peaked at two weeks. Hepatocytes were present in recovered chitosan capsules and expressed HBsAg mRNA. In allogeneic recipients, however, serum HBsAg disappeared within one week and recovered chitosan capsules showed lymphomononuclear cells but not hepatocytes. Transplantation of chitosan encapsulatd HbsAg secreting hepatocytes failed to induce an anti-HBs response, suggesting modulation of the host immune response. These results indicate that transplantation systems using genetically modified hepatocytes which secrete gene products in the blood of recipients should facilitate evaluation of hepatocyte encapsulation.

KW - bioartificial liver

KW - hepatitis B virus

KW - hepatocyte transplantation

KW - immobilized cells

KW - transgenic mouse

UR - http://www.scopus.com/inward/record.url?scp=0027288640&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027288640&partnerID=8YFLogxK

M3 - Article

VL - 16

SP - 155

EP - 163

JO - International Journal of Artificial Organs

JF - International Journal of Artificial Organs

SN - 0391-3988

IS - 3

ER -